{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:38:43Z","timestamp":1787787523953,"version":"build-2784847793"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Open Research Project of the State Key Laboratory of the Etiology and Prevention of High Incidence Diseases in Central Asia, Co-built by the Ministry and the Provinc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04341-3","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T09:03:39Z","timestamp":1778317419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Research progress on the biological function and molecular mechanism of GDF-15 in solid malignant tumors"],"prefix":"10.1186","volume":"24","author":[{"given":"Dilinaer","family":"Aishanjiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiliminuer","family":"Abulajiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reziya","family":"Saidula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaderya","family":"Abudusalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadierjiang","family":"Musha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"4341_CR1","doi-asserted-by":"publisher","first-page":"1514518","DOI":"10.3389\/fimmu.2024.1514518","volume":"15","author":"FI Isik","year":"2024","unstructured":"Isik FI, Thomson S, Cueto JF, et al. A systematic review of the neuroprotective role and biomarker potential of GDF15 in neurodegeneration [J]. Front Immunol. 2024;15:1514518.","journal-title":"Front Immunol"},{"issue":"1","key":"4341_CR2","doi-asserted-by":"publisher","first-page":"e13752","DOI":"10.1111\/acel.13752","volume":"22","author":"S Wedel","year":"2023","unstructured":"Wedel S, Martic I, Guerrero Navarro L, et al. Depletion of growth differentiation factor 15 (GDF15) leads to mitochondrial dysfunction and premature senescence in human dermal fibroblasts [J]. Aging Cell. 2023;22(1):e13752.","journal-title":"Aging Cell"},{"issue":"1","key":"4341_CR3","doi-asserted-by":"publisher","first-page":"5190","DOI":"10.1038\/s41467-024-49366-y","volume":"15","author":"P Chrysafi","year":"2024","unstructured":"Chrysafi P, Valenzuela-Vallejo L, Stefanakis K, et al. Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humans [J]. Nat Commun. 2024;15(1):5190.","journal-title":"Nat Commun"},{"key":"4341_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2020.11.002","volume":"57","author":"AC Eddy","year":"2021","unstructured":"Eddy AC, Trask AJ. Growth differentiation factor-15 and its role in diabetes and cardiovascular disease [J]. Cytokine Growth Factor Reviews. 2021;57:11\u20138.","journal-title":"Cytokine Growth Factor Reviews"},{"issue":"4","key":"4341_CR5","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/clinchem\/hvaa332","volume":"67","author":"JB Echouffo-Tcheugui","year":"2021","unstructured":"Echouffo-Tcheugui JB, Daya N, Matsushita K, et al. Growth differentiation factor (GDF)-15 and cardiometabolic outcomes among older adults: the atherosclerosis risk in communities\u2019 study [J]. Clin Chem. 2021;67(4):653\u201361.","journal-title":"Clin Chem"},{"issue":"1","key":"4341_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/ejendo\/lvaf135","volume":"193","author":"I Weigand","year":"2025","unstructured":"Weigand I, Triebig AS, Maier T, et al. Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15: impact on poor prognosis and impaired responsiveness to immunotherapy [J]. Eur J Endocrinol. 2025;193(1):146\u201355.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"4341_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2024.01305","volume":"19","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Dou L, Wang L, et al. Growth and differentiation factor 15: An emerging therapeutic target for brain diseases [J]. Biosci Trends. 2025;19(1):72\u201386.","journal-title":"Biosci Trends"},{"issue":"1","key":"4341_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4093\/dmj.2023.0115","volume":"48","author":"B Zhang","year":"2024","unstructured":"Zhang B, Chang JY, Lee MH, et al. Mitochondrial stress and mitokines: therapeutic perspectives for the treatment of metabolic diseases [J]. Diabetes metabolism J. 2024;48(1):1\u201318.","journal-title":"Diabetes metabolism J"},{"key":"4341_CR9","doi-asserted-by":"crossref","unstructured":"H\u00fcllwegen M, Kleinert M, von Haehling S, et al. GDF15: from biomarker to target in cancer cachexia [J]. Trends Cancer. 2025;11(11):1093\u2013105.","DOI":"10.1016\/j.trecan.2025.06.007"},{"issue":"1","key":"4341_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-physiol-022020-045449","volume":"83","author":"SN Breit","year":"2021","unstructured":"Breit SN, Brown DA, Tsai VW-W. The GDF15-GFRAL pathway in health and metabolic disease: friend or foe? [J]. Annu Rev Physiol. 2021;83(1):127\u201351.","journal-title":"Annu Rev Physiol"},{"key":"4341_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","volume":"64","author":"JA Siddiqui","year":"2022","unstructured":"Siddiqui JA, Pothuraju R, Khan P, et al. Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia [J]. Cytokine Growth Factor Reviews. 2022;64:71\u201383.","journal-title":"Cytokine Growth Factor Reviews"},{"issue":"1","key":"4341_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s13287-024-04030-6","volume":"15","author":"X Huang","year":"2024","unstructured":"Huang X, Liang X, Han Q, et al. Pretreatment with growth differentiation factor 15 augments cardio protection by mesenchymal stem cells in myocardial infarction by improving their survival [J]. Stem Cell Res Ther. 2024;15(1):412.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4341_CR13","doi-asserted-by":"publisher","first-page":"6699516","DOI":"10.1155\/2021\/6699516","volume":"2021","author":"Y Chen","year":"2021","unstructured":"Chen Y, Liu C, Zhou P, et al. Coronary endothelium No-reflow injury is associated with ROS\u2010modified mitochondrial fission through the JNK\u2010Drp1 signaling pathway [J]. Oxidative Med Cell Longev. 2021;2021(1):6699516.","journal-title":"Oxidative Med Cell Longev"},{"key":"4341_CR14","doi-asserted-by":"crossref","unstructured":"Zou A, Xiao T, Chi B, et al. Engineered exosomes with growth differentiation factor-15 overexpression enhance cardiac repair after myocardial injury [J]. Int J Nanomed. 2024;19:3295\u2013314.","DOI":"10.2147\/IJN.S454277"},{"issue":"3","key":"4341_CR15","doi-asserted-by":"publisher","first-page":"894","DOI":"10.62347\/MCYV5235","volume":"15","author":"C Xing","year":"2025","unstructured":"Xing C, Ding S, Duan T, et al. Epigenetic regulation and tumor suppressive function of lncRNA EP300-AS1 in nasopharyngeal carcinoma through activation of TFAP2C binding to CST6: implications for diagnosis, prognosis, and therapy [J]. Am J Cancer Res. 2025;15(3):894.","journal-title":"Am J Cancer Res"},{"key":"4341_CR16","doi-asserted-by":"publisher","first-page":"971278","DOI":"10.3389\/fimmu.2022.971278","volume":"13","author":"W Donelan","year":"2022","unstructured":"Donelan W, Dominguez-Gutierrez PR, Kusmartsev S. Deregulated hyaluronan metabolism in the tumor microenvironment drives cancer inflammation and tumor-associated immune suppression [J]. Front Immunol. 2022;13:971278.","journal-title":"Front Immunol"},{"key":"4341_CR17","doi-asserted-by":"crossref","unstructured":"Arias V, Kudling TV, Clubb JH, et al. Boosting anti-tumor immunity with TILT-517 oncolytic adenovirus and checkpoint blockade in renal cell carcinoma [J]. Mol Therapy Oncol. 2025;33(2):200979.","DOI":"10.1016\/j.omton.2025.200979"},{"issue":"1","key":"4341_CR18","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1038\/s41467-023-39817-3","volume":"14","author":"M Haake","year":"2023","unstructured":"Haake M, Haack B, Sch\u00e4fer T, et al. Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment [J]. Nat Commun. 2023;14(1):4253.","journal-title":"Nat Commun"},{"issue":"1","key":"4341_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12951-025-03182-8","volume":"23","author":"C Zou","year":"2025","unstructured":"Zou C, Liu X, Wang W, et al. Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticles [J]. J Nanobiotechnol. 2025;23(1):126.","journal-title":"J Nanobiotechnol"},{"key":"4341_CR20","doi-asserted-by":"crossref","unstructured":"Ghosh A, Michels J, Mezzadra R, et al. Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade [J]. J Clin Investig. 2022;132(18):e148141.","DOI":"10.1172\/JCI148141"},{"issue":"6230","key":"4341_CR21","first-page":"74","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment [. J] Science. 2015;348(6230):74\u201380.","journal-title":"J] Science"},{"issue":"8","key":"4341_CR22","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1158\/0008-5472.CAN-24-0086","volume":"84","author":"DJ Zabransky","year":"2024","unstructured":"Zabransky DJ, Chhabra Y, Fane ME, et al. Fibroblasts in the aged pancreas drive pancreatic cancer progression [J]. Cancer Res. 2024;84(8):1221\u201336.","journal-title":"Cancer Res"},{"issue":"1","key":"4341_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41413-021-00178-6","volume":"10","author":"JA Siddiqui","year":"2022","unstructured":"Siddiqui JA, Seshacharyulu P, Muniyan S, et al. GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation [J]. Bone Res. 2022;10(1):6.","journal-title":"Bone Res"},{"issue":"8048","key":"4341_CR24","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/s41586-024-08305-z","volume":"637","author":"I Melero","year":"2025","unstructured":"Melero I, de Miguel Luken M, de Velasco G, et al. Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours [J]. Nature. 2025;637(8048):1218\u201327.","journal-title":"Nature"},{"key":"4341_CR25","doi-asserted-by":"crossref","unstructured":"Bootcov MR, Bauskin AR, Valenzuela SM et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-\u03b2 superfamily [J]. Proc Nat Acad Sci. 1997;94(21):11514-9.","DOI":"10.1073\/pnas.94.21.11514"},{"issue":"12","key":"4341_CR26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.tem.2020.10.004","volume":"31","author":"L Rochette","year":"2020","unstructured":"Rochette L, Zeller M, Cottin Y, et al. Insights into mechanisms of GDF15 and receptor GFRAL: therapeutic targets [J]. Trends Endocrinol Metabolism. 2020;31(12):939\u201351.","journal-title":"Trends Endocrinol Metabolism"},{"key":"4341_CR27","doi-asserted-by":"publisher","first-page":"120645","DOI":"10.1016\/j.lfs.2022.120645","volume":"302","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chen J, Chen C, et al. Growth differentiation factor-15 overexpression promotes cell proliferation and predicts poor prognosis in cerebral lower-grade gliomas correlated with hypoxia and glycolysis signature [J]. Life Sci. 2022;302:120645.","journal-title":"Life Sci"},{"key":"4341_CR28","doi-asserted-by":"publisher","first-page":"217444","DOI":"10.1016\/j.canlet.2025.217444","volume":"611","author":"U Khatri","year":"2025","unstructured":"Khatri U, Gouda MA, Pandey S, et al. Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model [J]. Cancer Lett. 2025;611:217444.","journal-title":"Cancer Lett"},{"issue":"5","key":"4341_CR29","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1089\/thy.2020.0034","volume":"31","author":"YE Kang","year":"2021","unstructured":"Kang YE, Kim JM, Lim MA, et al. Growth differentiation factor 15 is a cancer cell-induced mitokine that primes thyroid cancer cells for invasiveness [J]. Thyroid. 2021;31(5):772\u201386.","journal-title":"Thyroid"},{"key":"4341_CR30","doi-asserted-by":"publisher","first-page":"820350","DOI":"10.3389\/fimmu.2022.820350","volume":"13","author":"DS Ahmed","year":"2022","unstructured":"Ahmed DS, Isnard S, Berini C, et al. Coping with stress: the mitokine GDF-15 as a biomarker of COVID-19 severity [J]. Frontiers Immunology. 2022;13:820350.","journal-title":"Frontiers Immunology"},{"key":"4341_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2023.11.029","volume":"116","author":"J Reyes","year":"2024","unstructured":"Reyes J, Zhao Y, Pandya K, et al. Growth differentiation factor-15 is an IFN-\u03b3 regulated mediator of infection-induced weight loss and the hepatic FGF21 response [J]. Brain Behav Immun. 2024;116:24\u201333.","journal-title":"Brain Behav Immun"},{"issue":"16","key":"4341_CR32","doi-asserted-by":"publisher","first-page":"11237","DOI":"10.1021\/acs.jmedchem.3c00667","volume":"66","author":"T Borner","year":"2023","unstructured":"Borner T, Tinsley IC, Milliken BT, et al. Creation of a peptide antagonist of the GFRAL\u2013RET receptor complex for the treatment of GDF15-induced malaise [J]. J Med Chem. 2023;66(16):11237\u201349.","journal-title":"J Med Chem"},{"key":"4341_CR33","doi-asserted-by":"crossref","unstructured":"Sabatini PV, Frikke-Schmidt H, Arthurs J et al. GFRAL-expressing neurons suppress food intake via aversive pathways [J]. Proc Nat Acad Sci. 2021;118(8):e2021357118.","DOI":"10.1073\/pnas.2021357118"},{"issue":"7968","key":"4341_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-023-06249-4","volume":"619","author":"D Wang","year":"2023","unstructured":"Wang D, Townsend LK, DesOrmeaux GJ, et al. GDF15 promotes weight loss by enhancing energy expenditure in muscle [J]. Nature. 2023;619(7968):143\u201350.","journal-title":"Nature"},{"key":"4341_CR35","doi-asserted-by":"publisher","first-page":"116809","DOI":"10.1016\/j.biopha.2024.116809","volume":"176","author":"J Li","year":"2024","unstructured":"Li J, Hu X, Xie Z, et al. Overview of growth differentiation factor 15 (GDF15) in metabolic diseases [J]. Biomed Pharmacother. 2024;176:116809.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"4341_CR36","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","volume":"17","author":"D Wang","year":"2021","unstructured":"Wang D, Day EA, Townsend LK, et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease [J]. Nat Reviews Endocrinol. 2021;17(10):592\u2013607.","journal-title":"Nat Reviews Endocrinol"},{"issue":"8","key":"4341_CR37","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.cmet.2023.06.009","volume":"35","author":"SN Breit","year":"2023","unstructured":"Breit SN, Manandhar R, Zhang HP, et al. GDF15 enhances body weight and adiposity reduction in obese mice by leveraging the leptin pathway [J]. Cell Metabol. 2023;35(8):1341\u2013e553.","journal-title":"Cell Metabol"},{"issue":"3","key":"4341_CR38","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/jcsm.13219","volume":"14","author":"BY Lee","year":"2023","unstructured":"Lee BY, Jeong J, Jung I, et al. GDNF family receptor alpha-like antagonist antibody alleviates chemotherapy-induced cachexia in melanoma-bearing mice [J]. J Cachexia Sarcopenia Muscle. 2023;14(3):1441\u201353.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"4341_CR39","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/jcsm.13435","volume":"15","author":"JD Groarke","year":"2024","unstructured":"Groarke JD, Crawford J, Collins SM, et al. Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design [J]. J Cachexia Sarcopenia Muscle. 2024;15(3):1054\u201361.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4341_CR40","doi-asserted-by":"crossref","unstructured":"Tang Y, Yao T, Tian X, et al. Hepatic IRE1\u03b1-XBP1 signaling promotes GDF15-mediated anorexia and body weight loss in chemotherapy [J]. J Exp Med. 2024;221(7):e20231395.","DOI":"10.1084\/jem.20231395"},{"key":"4341_CR41","doi-asserted-by":"crossref","unstructured":"Benichou O, Coskun T, Gonciarz MD et al. Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist [J]. Cell Metabol. 2023;35(2):274\u201386.e10.","DOI":"10.1016\/j.cmet.2022.12.011"},{"issue":"Pt 1","key":"4341_CR42","doi-asserted-by":"publisher","first-page":"116560","DOI":"10.1016\/j.bcp.2024.116560","volume":"230","author":"L Wang","year":"2024","unstructured":"Wang L, Huang JJ, Zhu WJ, et al. Curcumol effectively improves obesity through GDF15 induction via activation of endoplasmic reticulum stress response [J]. Biochem Pharmacol. 2024;230(Pt 1):116560.","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"4341_CR43","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s42255-024-01135-3","volume":"6","author":"AM Gurtan","year":"2024","unstructured":"Gurtan AM, Khalid S, Koch C, et al. Identification and characterization of human GDF15 knockouts [J]. Nat Metab. 2024;6(10):1913\u201321.","journal-title":"Nat Metab"},{"issue":"1","key":"4341_CR44","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s13287-024-04030-6","volume":"15","author":"X Huang","year":"2024","unstructured":"Huang X, Liang X, Han Q, et al. Pretreatment with growth differentiation factor 15 augments cardio protection by mesenchymal stem cells in myocardial infarction by improving their survival [J]. Stem Cell Res Ther. 2024;15(1):412.","journal-title":"Stem Cell Res Ther"},{"key":"4341_CR45","doi-asserted-by":"crossref","unstructured":"Chen Y, Liu C, Zhou P et al. Coronary Endothelium No-Reflow Injury Is Associated with ROS-Modified Mitochondrial Fission through the JNK-Drp1 Signaling Pathway [J]. Oxid Med Cell Longevity. 2021;2021:6699516.","DOI":"10.1155\/2021\/6699516"},{"key":"4341_CR46","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.2147\/IJN.S454277","volume":"19","author":"A Zou","year":"2024","unstructured":"Zou A, Xiao T, Chi B, et al. Engineered Exosomes with Growth Differentiation Factor-15 Overexpression Enhance Cardiac Repair After Myocardial Injury [J]. Int J Nanomed. 2024;19:3295\u2013314.","journal-title":"Int J Nanomed"},{"issue":"16","key":"4341_CR47","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1182\/blood.2019004572","volume":"136","author":"ES Hansen","year":"2020","unstructured":"Hansen ES, Hindberg K, Latysheva N, et al. Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism [J]. Blood. 2020;136(16):1863\u201370.","journal-title":"Blood"},{"key":"4341_CR48","doi-asserted-by":"publisher","first-page":"116475","DOI":"10.1016\/j.biopha.2024.116475","volume":"174","author":"BB Ny\u00e1r\u00e1dy","year":"2024","unstructured":"Ny\u00e1r\u00e1dy BB, Kiss LZ, Bagyura Z, et al. Growth and differentiation factor-15: A link between inflammaging and cardiovascular disease [J]. Biomed Pharmacother. 2024;174:116475.","journal-title":"Biomed Pharmacother"},{"key":"4341_CR49","doi-asserted-by":"publisher","first-page":"1377126","DOI":"10.3389\/fimmu.2024.1377126","volume":"15","author":"S Bu","year":"2024","unstructured":"Bu S, Royston L, Mabanga T, et al. Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity [J]. Front Immunol. 2024;15:1377126.","journal-title":"Front Immunol"},{"issue":"1","key":"4341_CR50","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s11357-023-00899-y","volume":"46","author":"LZ Kiss","year":"2024","unstructured":"Kiss LZ, Ny\u00e1r\u00e1dy BB, P\u00e1llinger \u00c9, et al. Association of growth and differentiation factor-15 with coronary artery calcium score and ankle-brachial index in a middle-aged and elderly Caucasian population sample free of manifest cardiovascular disease [J]. Geroscience. 2024;46(1):1343\u201350.","journal-title":"Geroscience"},{"issue":"10","key":"4341_CR51","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1038\/s41401-025-01561-3","volume":"46","author":"MN Liu","year":"2025","unstructured":"Liu MN, Liu ZH, Leng RX, et al. Revisiting the role of GDF15 in atherosclerosis in mouse and human [J]. Acta Pharmacol Sin. 2025;46(10):2663\u201376.","journal-title":"Acta Pharmacol Sin"},{"key":"4341_CR52","doi-asserted-by":"publisher","first-page":"101737","DOI":"10.1016\/j.arr.2022.101737","volume":"81","author":"R Gon\u00e7alves","year":"2022","unstructured":"Gon\u00e7alves R, Maciel \u00c1CC, Rolland Y, et al. Frailty biomarkers under the perspective of geroscience: A narrative review [J]. Ageing Res Rev. 2022;81:101737.","journal-title":"Ageing Res Rev"},{"issue":"10","key":"4341_CR53","doi-asserted-by":"publisher","first-page":"e036253","DOI":"10.1161\/JAHA.124.036253","volume":"14","author":"R Oppong","year":"2025","unstructured":"Oppong R, Orru V, Marongiu M, et al. Age-Associated Increase in Growth Differentiation Factor 15 Levels Correlates With Central Arterial Stiffness and Predicts All-Cause Mortality in a Sardinian Population Cohort [J]. J Am Heart Assoc. 2025;14(10):e036253.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"4341_CR54","doi-asserted-by":"publisher","first-page":"e00325","DOI":"10.1016\/j.neurot.2024.e00325","volume":"21","author":"BJ Shayota","year":"2024","unstructured":"Shayota BJ. Biomarkers of mitochondrial disorders [J]. Neurotherapeutics. 2024;21(1):e00325.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"4341_CR55","doi-asserted-by":"publisher","first-page":"e13715","DOI":"10.1002\/jcsm.13715","volume":"16","author":"SE Flaherty 3rd","year":"2025","unstructured":"Flaherty SE 3rd, Song L, Albuquerque B, et al. GDF15 Neutralization Ameliorates Muscle Atrophy and Exercise Intolerance in a Mouse Model of Mitochondrial Myopathy [J]. J Cachexia Sarcopenia Muscle. 2025;16(1):e13715.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4341_CR56","doi-asserted-by":"crossref","unstructured":"Van Hove JLK, Friederich MW, Strode DK, et al. Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases [J]. Hepatol Commun. 2024;8(1):e0361.","DOI":"10.1097\/HC9.0000000000000390"},{"issue":"1","key":"4341_CR57","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s10194-023-01563-8","volume":"24","author":"J He","year":"2023","unstructured":"He J, Zhou M, Zhao F, et al. FGF-21 and GDF-15 are increased in migraine and associated with the severity of migraine-related disability [J]. J Headache Pain. 2023;24(1):28.","journal-title":"J Headache Pain"},{"issue":"6","key":"4341_CR58","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/febs.16992","volume":"291","author":"SF Wang","year":"2024","unstructured":"Wang SF, Chang YL, Liu TY, et al. Mitochondrial dysfunction decreases cisplatin sensitivity in gastric cancer cells through upregulation of integrated stress response and mitokine GDF15 [J]. FEBS J. 2024;291(6):1131\u201350.","journal-title":"FEBS J"},{"issue":"6","key":"4341_CR59","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/febs.17087","volume":"291","author":"M Cavinato","year":"2024","unstructured":"Cavinato M. Mitochondrial dysfunction and cisplatin sensitivity in gastric cancer: GDF15 as a master player [J]. FEBS J. 2024;291(6):1111\u20134.","journal-title":"FEBS J"},{"issue":"5","key":"4341_CR60","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41419-023-05842-9","volume":"14","author":"B Yan","year":"2023","unstructured":"Yan B, Mei Z, Tang Y, et al. FGF21-FGFR1 controls mitochondrial homeostasis in cardiomyocytes by modulating the degradation of OPA1 [J]. Cell Death Dis. 2023;14(5):311.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4341_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40170-025-00373-7","volume":"13","author":"W Xue","year":"2025","unstructured":"Xue W, Li Y, Ma Y, et al. GDF15-mediated enhancement of the Warburg effect sustains multiple myeloma growth via TGF\u03b2 signaling pathway [J]. Cancer Metab. 2025;13(1):3.","journal-title":"Cancer Metab"},{"key":"4341_CR62","doi-asserted-by":"publisher","first-page":"966644","DOI":"10.3389\/fendo.2022.966644","volume":"13","author":"S Jeong","year":"2022","unstructured":"Jeong S, Lee SG, Kim KH, et al. Cell non-autonomous effect of hepatic growth differentiation factor 15 on the thyroid gland [J]. Front Endocrinol (Lausanne). 2022;13:966644.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4341_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41420-020-00395-8","volume":"7","author":"S Zhu","year":"2021","unstructured":"Zhu S, Yang N, Guan Y, et al. GDF15 promotes glioma stem cell-like phenotype via regulation of ERK1\/2-c-Fos-LIF signaling [J]. Cell Death Discov. 2021;7(1):3.","journal-title":"Cell Death Discov"},{"key":"4341_CR64","doi-asserted-by":"publisher","first-page":"204173142513577","DOI":"10.1177\/20417314251357752","volume":"16","author":"P Deng","year":"2025","unstructured":"Deng P, Yang B, Huang C, et al. GDF15 promotes osteogenic differentiation of human dental pulp stem cells by activating the TGF-\u03b2\/SMAD signaling pathway [J]. J Tissue Eng. 2025;16:20417314251357752.","journal-title":"J Tissue Eng"},{"key":"4341_CR65","doi-asserted-by":"publisher","first-page":"119356","DOI":"10.1016\/j.lfs.2021.119356","volume":"275","author":"A Li","year":"2021","unstructured":"Li A, Zhao F, Zhao Y, et al. ATF4-mediated GDF15 suppresses LPS-induced inflammation and MUC5AC in human nasal epithelial cells through the PI3K\/Akt pathway [J]. Life Sci. 2021;275:119356.","journal-title":"Life Sci"},{"key":"4341_CR66","doi-asserted-by":"crossref","unstructured":"Wang Z, He L, Li W, et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma [J]. J Immunother Cancer. 2021;9(9):e002787.","DOI":"10.1136\/jitc-2021-002787"},{"key":"4341_CR67","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.molimm.2025.07.006","volume":"185","author":"R Li","year":"2025","unstructured":"Li R, Wu H, Ran F, et al. GDF15 activates the PI3K\/AKT pathway to mediate macrophage M2 polarization to promote prostate cancer resistance to docetaxel [J]. Mol Immunol. 2025;185:27\u201338.","journal-title":"Mol Immunol"},{"key":"4341_CR68","doi-asserted-by":"crossref","unstructured":"Cao G, Wang Y, Zeng H et al. Oligoclonal tumor-specific CD8 T-cell revival and IRE1\u03b1\/XBP1-GDF15-mediated immunosuppressive niches determine neoadjuvant chemoimmunotherapy efficacy in cervical cancer [J]. J Immunother Cancer. 2025;13(11).","DOI":"10.1136\/jitc-2025-012630"},{"key":"4341_CR69","doi-asserted-by":"publisher","first-page":"1550003","DOI":"10.3389\/fimmu.2025.1550003","volume":"16","author":"T Xu","year":"2025","unstructured":"Xu T, Zhang H, Yang B, et al. Tumor-infiltrating immune cells state-implications for various breast cancer subtypes. Front Immunol. 2025;16:1550003.","journal-title":"Front Immunol"},{"issue":"3","key":"4341_CR70","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.7150\/thno.51383","volume":"11","author":"J Chen","year":"2021","unstructured":"Chen J, Ding ZY, Li S, et al. Targeting transforming growth factor-\u03b2 signaling for enhanced cancer chemotherapy [J]. Theranostics. 2021;11(3):1345\u201363.","journal-title":"Theranostics"},{"key":"4341_CR71","doi-asserted-by":"publisher","first-page":"1608712","DOI":"10.3389\/fonc.2025.1608712","volume":"15","author":"L Liu","year":"2025","unstructured":"Liu L, Pei Q, Qadir J, et al. Application of artificial intelligence-based stemness index in cancer. Front Oncol. 2025;15:1608712.","journal-title":"Front Oncol"},{"issue":"8048","key":"4341_CR72","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/s41586-024-08305-z","volume":"637","author":"I Melero","year":"2025","unstructured":"Melero I, de Miguel Luken M, de Velasco G, et al. Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumors [J]. Nature. 2025;637(8048):1218\u201327.","journal-title":"Nature"},{"issue":"1","key":"4341_CR73","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41420-022-00972-z","volume":"8","author":"W Zhang","year":"2022","unstructured":"Zhang W, Sun W, Gu X, et al. GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2\/caspase-3 pathway [J]. Cell Death Discov. 2022;8(1):162.","journal-title":"Cell Death Discov"},{"issue":"1","key":"4341_CR74","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1038\/s41467-023-39817-3","volume":"14","author":"M Haake","year":"2023","unstructured":"Haake M, Haack B, Sch\u00e4fer T, et al. Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment [J]. Nat Commun. 2023;14(1):4253.","journal-title":"Nat Commun"},{"key":"4341_CR75","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","volume":"11","author":"J Wischhusen","year":"2020","unstructured":"Wischhusen J, Melero I, Fridman WH. Growth\/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint [J]. Front Immunol. 2020;11:951.","journal-title":"Front Immunol"},{"issue":"10","key":"4341_CR76","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/bjc.2011.112","volume":"104","author":"U Wallin","year":"2011","unstructured":"Wallin U, Glimelius B, Jirstr\u00f6m K, et al. Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer [J]. Br J Cancer. 2011;104(10):1619\u201327.","journal-title":"Br J Cancer"},{"key":"4341_CR77","doi-asserted-by":"publisher","first-page":"1619387","DOI":"10.3389\/fimmu.2025.1619387","volume":"16","author":"R Xing","year":"2025","unstructured":"Xing R, Gan J, Mei J, et al. Serum GDF15 level as predictive biomarker of clinical outcome in patients with unresectable hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy [J]. Front Immunol. 2025;16:1619387.","journal-title":"Front Immunol"},{"key":"4341_CR78","doi-asserted-by":"crossref","unstructured":"Breen DM, Kim H, Bennett D et al. GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates [J]. Cell Metabol. 2020;32(6): 938\u201350.e6.","DOI":"10.1016\/j.cmet.2020.10.023"},{"key":"4341_CR79","doi-asserted-by":"publisher","first-page":"891448","DOI":"10.3389\/fimmu.2022.891448","volume":"13","author":"M Cao","year":"2022","unstructured":"Cao M, Gu L, Guo L, et al. Elevated Expression of Growth Differentiation Factor-15 Is Associated With Acute Exacerbation of Idiopathic Pulmonary Fibrosis [J]. Front Immunol. 2022;13:891448.","journal-title":"Front Immunol"},{"issue":"26","key":"4341_CR80","doi-asserted-by":"publisher","first-page":"e2403858","DOI":"10.1002\/advs.202403858","volume":"11","author":"L He","year":"2024","unstructured":"He L, Li Z, Su D, et al. Tumor Microenvironment-Responsive Nanocapsule Delivery CRISPR\/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma [J]. Adv Sci. 2024;11(26):e2403858.","journal-title":"Adv Sci"},{"key":"4341_CR81","doi-asserted-by":"crossref","unstructured":"Melero I, Luken M, d M, Garralda E et al. 519 GDFATHER-01 trial longterm follow-up: GDF-15 neutralization combined with nivolumab can enable deep, longterm remission in heavily pretreated, anti-PD1\/-L1 relapsed\/refractory major solid tumor types [J]. J Immunother Cancer. 2025;13(Suppl 2).","DOI":"10.1136\/jitc-2025-SITC2025.0519"},{"key":"4341_CR82","doi-asserted-by":"crossref","unstructured":"Melero I, Luken M d M, Garralda E, et al. GDFATHER-01 trial longterm follow-up: GDF-15 neutralization combined with nivolumab can enable deep, longterm remission in heavily pretreated, anti-PD1\/-L1 relapsed\/refractory major solid tumor types[J]. J Immunother Cancer. 2025;13(Suppl 2). BMJ Publishing Group Ltd","DOI":"10.1136\/jitc-2025-SITC2025.0519"},{"key":"4341_CR83","unstructured":"Groarke JD, Crawford J, Collins SM et al. Ponsegromab in Cancer Cachexia [J]. N Engl J Med. 2024."},{"issue":"6","key":"4341_CR84","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1158\/2767-9764.CRC-24-0565","volume":"5","author":"BA Carneiro","year":"2025","unstructured":"Carneiro BA, Gbolahan OB, Abdul Razak AA, et al. First-in-human study to evaluate the safety and efficacy of anti-GDF15 antibody AZD8853 in patients with advanced\/metastatic solid tumors [J]. Cancer Res Commun. 2025;5(6):896\u2013905.","journal-title":"Cancer Res Commun"},{"issue":"3","key":"4341_CR85","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1158\/1078-0432.CCR-23-1631","volume":"30","author":"J Crawford","year":"2024","unstructured":"Crawford J, Calle RA, Collins SM, et al. A phase Ib first-in-patient study assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of ponsegromab in participants with cancer and cachexia [J]. Clin Cancer Res. 2024;30(3):489\u201397.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4341_CR86","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.62347\/WTCF3616","volume":"15","author":"S Yamashita","year":"2025","unstructured":"Yamashita S, Okugawa Y, Higashi K, et al. Direct triangular comparison of tissue and serum growth differentiation factor 15 with host factors in colorectal cancer [J]. Am J Cancer Res. 2025;15(3):1174.","journal-title":"Am J Cancer Res"},{"key":"4341_CR87","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1016\/j.annonc.2025.08.584","volume":"36","author":"J Berger","year":"2025","unstructured":"Berger J, Englisch C, Kleinberger M, et al. 150P Correlation of GDF-15 with clinical characteristics, entity, inflammation and therapy response in patients with solid cancer [J]. Ann Oncol. 2025;36:S265\u20136.","journal-title":"Ann Oncol"},{"issue":"6","key":"4341_CR88","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1093\/jalm\/jfac055","volume":"7","author":"Y Karusheva","year":"2022","unstructured":"Karusheva Y, Ratcliff M, M\u00f6rseburg A, et al. The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating Levels [J]. J Appl Lab Med. 2022;7(6):1388\u2013400.","journal-title":"J Appl Lab Med"},{"issue":"11","key":"4341_CR89","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1111\/1471-0528.17129","volume":"129","author":"MS Fejzo","year":"2022","unstructured":"Fejzo MS, MacGibbon KW, First O, et al. Whole-exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum [J]. BJOG. 2022;129(11):1845\u201352.","journal-title":"BJOG"},{"key":"4341_CR90","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2023.11.029","volume":"116","author":"J Reyes","year":"2024","unstructured":"Reyes J, Zhao Y, Pandya K, et al. Growth differentiation factor-15 is an IFN-\u03b3 regulated mediator of infection-induced weight loss and the hepatic FGF21 response [J]. Brain Behav Immun. 2024;116:24\u201333.","journal-title":"Brain Behav Immun"},{"key":"4341_CR91","doi-asserted-by":"publisher","first-page":"106068","DOI":"10.1016\/j.bbi.2025.106068","volume":"130","author":"CC Liu","year":"2025","unstructured":"Liu CC, Trumpff C, Huang Q, et al. Biopsychosocial correlates of resting and stress-reactive salivary GDF15: preliminary findings [J]. Brain Behav Immun. 2025;130:106068.","journal-title":"Brain Behav Immun"},{"key":"4341_CR92","doi-asserted-by":"crossref","unstructured":"Johann K, Kleinert M, Klaus S. The Role of GDF15 as a Myomitokine [J]. Cells. 2021;10(11).","DOI":"10.3390\/cells10112990"},{"issue":"12","key":"4341_CR93","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/j.cmet.2023.11.003","volume":"35","author":"JF Lu","year":"2023","unstructured":"Lu JF, Zhu MQ, Xia B, et al. GDF15 is a major determinant of ketogenic diet-induced weight loss [J]. Cell Metabol. 2023;35(12):2165\u2013e827.","journal-title":"Cell Metabol"},{"issue":"11","key":"4341_CR94","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.tem.2022.08.004","volume":"33","author":"D Aguilar-Recarte","year":"2022","unstructured":"Aguilar-Recarte D, Barroso E, Palomer X, et al. Knocking on GDF15\u2019s door for the treatment of type 2 diabetes mellitus [J]. Trends Endocrinol Metabolism. 2022;33(11):741\u201354.","journal-title":"Trends Endocrinol Metabolism"},{"issue":"1","key":"4341_CR95","doi-asserted-by":"publisher","first-page":"7173","DOI":"10.1038\/s41467-024-51078-2","volume":"15","author":"L L\u2019Homme","year":"2024","unstructured":"L\u2019Homme L, Sermikli BP, Haas JT, et al. Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASH [J]. Nat Commun. 2024;15(1):7173.","journal-title":"Nat Commun"},{"key":"4341_CR96","doi-asserted-by":"crossref","unstructured":"Adela R, Banerjee SK. GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective [J]. J Diabetes Res. 2015;2015:490842.","DOI":"10.1155\/2015\/490842"},{"key":"4341_CR97","doi-asserted-by":"publisher","first-page":"176894","DOI":"10.1016\/j.ejphar.2024.176894","volume":"982","author":"X Li","year":"2024","unstructured":"Li X, Sun H, Zhang L, et al. GDF15 attenuates sepsis-induced myocardial dysfunction by inhibiting cardiomyocytes ferroptosis via the SOCS1\/GPX4 signaling pathway [J]. Eur J Pharmacol. 2024;982:176894.","journal-title":"Eur J Pharmacol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04341-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04341-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04341-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:02:25Z","timestamp":1784858545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04341-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4341"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04341-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"27 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agree and give consent for the publication of this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"310"}}